Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Divyajot Sandhu

Vascular Neurology Sioux Falls, SD Medical Doctor

NPI 1790915973 CMS profile 1393451

1210 W 18Th St Ste 100, Sioux Falls, SD 57104

Open in the dashboard

General payments

$14,053

143 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$293,494 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Divyajot Sandhu of Sioux Falls, SD is reported in the CMS Open Payments database as having received $14,053 across 143 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $293,494 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 86th percentile of Vascular Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,074 25
2024 General $3,651 21
2023 General $707 12
2022 General $375 8
2021 General $1,688 20
2020 General $384 11
2019 General $4,173 46

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Divyajot Sandhu
  • Vascular Neurology median
  • Middle half of Vascular Neurology
  • National median

In program year 2025, general payments to Divyajot Sandhu were reported at $3,074. Among 416 Vascular Neurology profiles paid that year, the median was $360 and the middle half received between $91 and $1,472.

Show as a table
Year Divyajot Sandhu Vascular Neurology median Middle half National median
2019 $4,173 $263 $102–$1,640 $163
2020 $384 $153 $45–$1,000 $114
2021 $1,688 $261 $100–$1,355 $132
2022 $375 $242 $87–$1,273 $149
2023 $707 $322 $97–$1,266 $160
2024 $3,651 $247 $70–$1,053 $164
2025 $3,074 $360 $91–$1,472 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. MicroVention, Inc. $11,067 99 payments
  2. Stryker Corporation $1,002 7 payments
  3. DePuy Synthes Sales Inc. $850 14 payments
  4. Imperative Care, INc $357 7 payments
  5. Route 92 Medical, Inc. $192 4 payments
  6. Microtransponder, Inc. $164 1 payment
  7. Penumbra, Inc. $157 2 payments
  8. Medtronic, Inc. $122 3 payments
  9. Terumo Medical Corporation $83 3 payments
  10. Genentech USA, Inc. $25 1 payment
  11. Other $33 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,372 119 payments
  2. Travel and Lodging $6,180 22 payments
  3. Consulting Fee $1,500 2 payments
Products named General payments · program years 2019–2025
  1. ERIC RETRIEVAL DEVICE $3,598 14 payments
  2. WEB $3,377 40 payments
  3. WEB ANEURYSM EMBOLIZATION SYSTEM Neurological Product $2,886 19 payments
  4. SOFIA 6F-131CM STR Neurological Product $1,920 8 payments
  5. STENT $1,453 9 payments
  6. WEB Aneurysm Embolization System Neurological Product $1,391 12 payments
  7. Azur CX Detachable $1,123 6 payments
  8. LVIS $1,013 4 payments
  9. SOFIA 6F-131CM STR Neurological Product $932 5 payments
  10. CHAPERON GUIDING CATHETER $896 5 payments
  11. Other $6,656 90 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

67

Median for Neurology: 833

Drug cost

$4,542

Median for Neurology: $202,670

Branded share of claims

62.7%

Median for Neurology: 25.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Brilinta Ticagrelor Brand 13 $4,187
Clopidogrel Clopidogrel Bisulfate Brand 29 $171
Oxcarbazepine Generic 13 $147
Atorvastatin Calcium Generic 12 $37

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,695 Part D prescribers listed as Neurology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$94,972

Medicare's payments for the services billed

Medicare patients

222

Average age 76

Services billed

725

114 women, 108 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 50%
Ischemic heart disease 48%
Depression 38%
Diabetes 36%
Chronic kidney disease 36%
Atrial fibrillation 34%
Heart failure 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

143 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Neurology in South Dakota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record